Reach Neuro
Overview
We are an early stage startup developing the first-ever treatment for chronic disability caused by stroke.
Funding and backers
Total raised
$200k
1 round on record
Latest round
$200k
Convertible Note · Jul 2022 · 4 yr ago
Backers
1
SOSV
The money's age
Long since its last round
51 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Convertible Note | Jul 2022 | $200k | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Reach Neuro, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Marc PowellExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
About Us BioKier Inc. is an early-stage pharmaceutical company developing new proprietary medical foods and drugs for diabetes and related…
Startup Vessel is a startup software directory for founder workflows, early-stage operations, and startup execution.
Temprian Therapeutics is an early-stage biotechnology company treating vitiligo through a novel treatment that blocks the autoimmune…
FemtoSenseLabs is an early-stage R&D company developing affordable, advanced quantum sensors for medical, navigation, and human-machine…
Innovationand Impact. As an early-stage startup, we are looking to make a significant impact.
Epitome Therapeutics is an early-stage biotechnology company, focused on developing a next-generation epigenome editing platform to…
Financials
Total raised
$200k
Latest round
Convertible Note
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Convertible Note | 2022 | $200k | Details |
People
Marc Powell
Executive Officer, Director
Douglas Weber
Director
Marco Capogrosso
Director
Peter Gerszten
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
SOSVVia a fund
780 portfolio companies
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Pittsburgh
United States
HQ